ACCESSING HIDDEN THERAPEUTICS IN NATURE

 

ABOUT US

Silenyx is a Princeton-based biopharmaceutical company that is opening new doors to drug discovery by tapping into hidden therapeutics in nature. Although historically prolific, recent investments into natural products have delivered diminishing returns due to the costly rediscovery of known compounds. This is in part due to the silent nature of most biosynthetic genes: conventional methods only capture ~10% of a bacterium’s biosynthetic potential. Using a broadly applicable, high-throughput, genetics-free, and cloning-free approach, Silenyx provides the simplest and fastest natural product drug discovery platform which can rapidly activate silent biosynthetic genes, unlocking the full potential of any culturable microbe.

 

OUR TECHNOLOGY

Our Platform, HiTES (High‐Throughput Elicitor Screening) is a facile, rapid, patent-protected and high-throughput method for activation of any desired silent biosynthetic gene cluster. Recent research has shown that 80‐90% of all biosynthetic gene clusters – the sets of genes responsible for the synthesis of a given natural product – are ‘silent’ or ‘cryptic’, meaning their small molecule products are not biosynthesized under standard growth conditions. Accordingly, these cryptic natural products have not been interrogated in routine drug discovery screens.

 
Picture1.png

MOHAMMAD R. “MO” SEYEDSAYAMDOST, PHD

Co-Founder and CSO

Trained at MIT and Harvard Medical School before joining Princeton University as an Assistant Professor, Dr. Seyedsayamdost has developed the technology based on his own pioneering research. He is currently Associate Professor of Chemistry & Molecular Biology."

STEVE REECE, PHD

Co-Founder and CEO

Trained at Massachusetts Institute of Technology and UC Berkeley, Dr. Reece has over a decade of start-up, commercialization, and acquisition experience. Dr. Reece spun-out Sun Catalytix from MIT which was acquired by Lockheed Martin with the intent to launch the acquired technology in the coming year.

steve_edited.png
IMG_5709.JPG

MARYAM ELFEKI, PHD

Co-Founder and COO

Trained at University of Illinois at Chicago and Princeton University, Dr. Elfeki brings her microbial natural product expertise as well as her energetic and entrepreneurial spirit to Silenyx.

 

GET IN TOUCH

Frick Chemistry Lab, Rm 333
Washington Road
Princeton, NJ 08544

 
  • LinkedIn

©2020 by Silenyx.com. Proudly created with Wix.com